Neurotech International Ownership

NTI Stock   0.05  0  6.00%   
Neurotech International maintains a total of 1.04 Billion outstanding shares. Neurotech International holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2015-09-30
Previous Quarter
876.8 M
Current Value
947.1 M
Avarage Shares Outstanding
345.1 M
Quarterly Volatility
338.8 M
 
Yuan Drop
 
Covid
Dividends Paid is likely to drop to about 5.1 M in 2025. Common Stock Shares Outstanding is likely to gain to about 1.1 B in 2025, whereas Net Loss is likely to drop (793.2 K) in 2025.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurotech International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Neurotech Stock Ownership Analysis

About 33.0% of the company outstanding shares are owned by corporate insiders. The book value of Neurotech International was now reported as 0.01. The company recorded a loss per share of 0.01. Neurotech International had not issued any dividends in recent years. The entity had 8:7 split on the 1st of February 2019. To find out more about Neurotech International contact the company at 61 8 9389 3130 or learn more at https://www.neurotechinternational.com.

Neurotech International Outstanding Bonds

Neurotech International issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Neurotech International uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Neurotech bonds can be classified according to their maturity, which is the date when Neurotech International has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Neurotech Stock Analysis

When running Neurotech International's price analysis, check to measure Neurotech International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurotech International is operating at the current time. Most of Neurotech International's value examination focuses on studying past and present price action to predict the probability of Neurotech International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurotech International's price. Additionally, you may evaluate how the addition of Neurotech International to your portfolios can decrease your overall portfolio volatility.